AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
19
Employees19
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
19
Employees19

AIM Key Statistics

Market cap
7.04M
Market cap7.04M
Price-Earnings ratio
-0.06
Price-Earnings ratio-0.06
Dividend yield
Dividend yield
Average volume
20.59M
Average volume20.59M
High today
$0.24
High today$0.24
Low today
$0.223
Low today$0.223
Open price
$0.232
Open price$0.232
Volume
9.32M
Volume9.32M
52 Week high
$2.98
52 Week high$2.98
52 Week low
$0.1901
52 Week low$0.1901

Stock Snapshot

AIM ImmunoTech(AIM) stock is priced at $0.23, giving the company a market capitalization of 7.04M. It carries a P/E multiple of -0.06.

On 2026-09-07, AIM ImmunoTech(AIM) stock traded between a low of $0.22 and a high of $0.24. Shares are currently priced at $0.23, which is +3.3% above the low and -4.0% below the high.

The AIM ImmunoTech(AIM)'s current trading volume is 9.32M, compared to an average daily volume of 20.59M.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.19 at its lowest and $2.98 at its peak.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.19 at its lowest and $2.98 at its peak.

AIM News

TipRanks 2d
AIM ImmunoTech Extinguishes Debt Through Equity Exchanges

AIM ImmunoTech ( (AIM) ) just unveiled an announcement. Between August 31 and September 3, 2026, AIM ImmunoTech entered into five exchange agreements and relat...

TipRanks 7d
AIM ImmunoTech granted patent for Ampligen

AIM ImmunoTech (AIM) announced that the United States Patent and Trademark Office has granted a patent covering the use of the company’s drug Ampligen in combin...

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.